1. Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome
2. An analysis of FDA‐approved drugs for neurological disorders;Klinch M.S.;Drug Discov. Today,2015
3. Incidence and prevalence of major neurologic disorders;Pal S.;US Pharm.,2018
4. US Food and Drug Administration(2021).Novel drug approvals for 2021.https://www.fda.gov/drugs/new‐drugs‐fda‐cders‐new‐molecular‐entities‐and‐new‐therapeutic‐biological‐products/novel‐drug‐approvals‐2021(accessed 8 February 2023).
5. US Food and Drug Administration(2016).Novel drug approvals for 2016.https://www.fda.gov/drugs/new‐drugs‐fda‐cders‐new‐molecular‐entities‐and‐new‐therapeutic‐biological‐products/novel‐drug‐approvals‐2016(accessed 8 February 2023).